Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Dyne Therapeutics, Inc. (DYN) had Cash Flow from Financial Activities of $54.32M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-235.94M |
|
-- |
|
-- |
|
$242.16M |
|
$-242.16M |
|
$6.22M |
|
$-235.94M |
|
$-235.94M |
|
$-235.94M |
|
$-235.94M |
|
$-235.94M |
|
$-235.94M |
|
$-242.16M |
|
$-241.59M |
|
59.68M |
|
59.68M |
|
$-3.95 |
|
$-3.95 |
|
| Balance Sheet Financials | |
$129.38M |
|
$4.78M |
|
$35.71M |
|
$165.08M |
|
$51.09M |
|
-- |
|
$22.70M |
|
$73.79M |
|
$91.29M |
|
$91.29M |
|
$91.29M |
|
61.47M |
|
| Cash Flow Statement Financials | |
$-188.16M |
|
$83.31M |
|
|
Cash Flow from Financial Activities |
$54.32M |
$174.47M |
|
$123.94M |
|
$-50.52M |
|
$19.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-188.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-258.44% |
|
-258.44% |
|
-142.92% |
|
-258.44% |
|
$1.49 |
|
$-3.16 |
|
$-3.15 |
|